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Influenza B virus causes annual epidemics and along with influenza A virus accounts for substantial 19 
disease and economic burden throughout the world. Influenza B infects only humans and some marine 20 
mammals and is not responsible for pandemics possibly due to a very low frequency of reassortation 21 
and a lower evolutionary rate compared to influenza A virus. Influenza B virus has been less studied 22 
than influenza A and thus a comparison of influenza A and B virus infection mechanisms may provide 23 
new insight into virus-host interactions. Here we analyzed the early events in influenza B virus 24 
infection and interferon (IFN) gene expression in human monocyte-derived macrophages and dendritic 25 
cells. We show that influenza B virus induces IRF3 activation and IFN-λ1 gene expression with a faster 26 
kinetics compared to influenza A virus without a requirement for viral protein synthesis or replication. 27 
Influenza B virus-induced activation of IRF3 required the fusion of viral and endosomal membranes 28 
and nuclear accumulation of IRF3 and viral NP occurred concurrently. In comparison, immediate early 29 
IRF3 activation was not observed in influenza A virus-infected macrophages. Experiments with RIG-I, 30 
MDA5 and RIG-I/MDA5 deficient mouse fibroblasts showed that RIG-I is the critical pattern 31 
recognition receptor needed for the influenza B virus-induced activation of IRF3. Our results show that 32 
innate immune mechanisms are activated immediately after influenza B virus entry through the 33 
endocytic pathway, whereas influenza A virus avoids the early IRF3 activation and IFN gene induction. 34 
 35 
IMPORTANCE  36 
Recently, a great deal of interest has been paid on identifying the ligands for RIG-I under a natural 37 
infection as many of the previous studies have been based on transfecting the cells with different types 38 
of viral or synthetic RNA structures. We shed light on this question by analyzing the earliest step in 39 
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innate immune recognition of influenza B virus by human macrophages. We show that influenza B 40 
virus induces IRF3 activation leading to the IFN gene expression after the viral vRNPs are released to 41 
the cytosol and are recognized by RIG-I receptor meaning that already the incoming influenza B virus 42 
is able to activate IFN gene expression. In contrast, influenza A (H3N2) virus failed to activate IRF3 at 43 
very early times of infection suggesting that there are differences in the innate immune recognition 44 
between influenza A and B viruses. 45 
 46 
INTRODUCTION 47 
Influenza A and B viruses are important respiratory pathogens and cause seasonal epidemics with an 48 
estimated 250 000 - 500 000 annual deaths. Influenza A and B viruses are structurally similar; they are 49 
negative sense RNA viruses with a single-stranded segmented genome. The genome is structured in 50 
eight viral ribonucleoprotein (vRNP) complexes where the ssRNA is associated with multiple 51 
nucleoprotein (NP) molecules and a polymerase complex consisting of PB1, PB2 and PA proteins (1).  52 
The vRNP complexes are packaged in a matrix protein shell surrounded by a host-derived lipid 53 
envelope in which the viral glycoproteins hemagglutinin (HA) and neuraminidase (NA) are embedded. 54 
Influenza viruses bind to sialic acids on cell surface glycoproteins and enter the cells mainly via a 55 
clathrin-mediated endocytosis but also by macropinocytosis and clathrin-independent entry pathways 56 
(2, 3). Influenza viruses take advantage of the host endocytic pathway; a reduction of pH during the 57 
maturation of endosomes induces a conformational change in viral HA molecules and triggers the 58 
fusion between viral and endosomal membranes. The fusion is followed by the uncoating of the capsid 59 
by M1 dissociation due to acidification of the virion via M2 ion channel protein.  This results in the 60 
release of vRNPs into the cytosol. The influenza virus genome is then imported into the nucleus for 61 
transcription and replication of viral genes. Primary transcription of the viral genome is triggered by the 62 
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virion-associated polymerase protein complex which leads to the translation of early viral proteins in 63 
the cell cytoplasm. Newly synthesized polymerase, NP and NS1 proteins are transported into the 64 
nucleus, where they initiate and regulate the replication and synthesis of complementary (cRNA) and 65 
viral RNA (vRNA) molecules followed by secondary rounds of transcription. At later stages of the 66 
infection, new vRNP complexes are packaged in the nucleus followed by M1 and NEP-regulated 67 
export of vRNPs into the cytoplasm. Here, they associate with viral envelope glycoproteins HA and 68 
NA on the plasma membrane leading to budding of the newly formed viral particles (4).  69 
Host cells respond to influenza virus infection by producing interferons (IFN) and antiviral proteins 70 
thus establishing an antiviral cellular state to restrict the spread of the infection. The most important 71 
cellular sensors for RNA viruses are cytosolic retinoic acid-inducible gene-I (RIG-I) -like receptors 72 
(RLRs), RIG-I and melanoma differentiation-associated protein 5 (MDA5), which recognize and bind 73 
virus-derived ssRNA and dsRNA structures (5-7). Endosomal Toll-like receptors (TLRs), such as 74 
TLR3 and TLR7/8 also recognize viral dsRNAs and ssRNAs, respectively (8-11). RLRs and TLRs 75 
regulate IFN and other proinflammatory cytokine responses during influenza infection in certain cell 76 
types. However, it remains unclear at what point in the influenza virus entry and/or replication cycle 77 
viral RNA is sensed and IFN gene expression is induced. One study suggested that influenza A virus 78 
RNA synthesis and nuclear export but not viral replication triggers IFN gene expression (12). Other 79 
studies have proposed that RIG-I can recognize the incoming negative sense RNA virus via its 5’-80 
triphosphorylated genomic RNA even though it is bound by NP proteins and the viral RNA polymerase 81 
complex (13-15). It has also been suggested that the incoming influenza A virus carries certain viral 82 
structures that inhibit RIG-I activation and IFN induction even though the viral RNA is recognized by 83 
RIG-I at the time of entry into the cytosol (16). 84 
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Upon binding of ssRNA or some dsRNA molecules RIG-I oligomerizes and associates with the adaptor 85 
protein mitochondrial antiviral-signaling protein (MAVS) on mitochondrial-associated membrane 86 
(MAM) and the outer membrane of mitochondria (17, 18). This activates a signaling cascade, which 87 
leads to serine/threonine-protein kinase TBK1/IKKε-mediated phosphorylation and nuclear 88 
translocation of the transcription factor interferon regulatory factor 3 (IRF3) and induction of IFN 89 
genes (18, 19).  RIG-I signaling also can induce the activation of classical kinases IΚΚα and IΚΚβ, 90 
which promote signaling by the nuclear factor (NF)-κB and mitogen-activated protein kinase (MAPK) 91 
pathways (19). To counteract virus-induced activation of IFN gene expression, influenza A and B 92 
viruses have evolved mechanisms to inhibit the activation of innate immunity. The best known 93 
conserved virulence factor of influenza A and B viruses is the multifunctional NS1 protein which can 94 
inhibit RIG-I signaling and interfere with the processing of host cell pre-mRNA molecules (20). 95 
Influenza A virus also encodes additional virulence factors (PB1-F2, PB1-N40 and PA-X proteins) that 96 
antagonize innate immune responses (21-23). 97 
Most information on influenza virus lifecycle and immune restriction has been obtained from influenza 98 
A virus research and it has been presumed that influenza B virus behaves in a similar fashion. 99 
However, we suggest that there may be differences between the viruses regarding the activation 100 
mechanisms of IFN gene expression. We have shown previously that influenza B virus induces a very 101 
rapid IFN response in human monocyte-derived dendritic cells (moDC) that does not depend on 102 
transcription or replication of the virus (24). Herein, we show that the early influenza B virus-induced 103 
IFN gene expression is RIG-I dependent and takes place after the vRNPs are released into the cytosol. 104 
These conclusions are supported by detailed gene expression analyses, cell biological approaches and 105 




MATERIALS AND METHODS 108 
Ethics Statement. Adult human blood was obtained from anonymous healthy blood donors through 109 
the Finnish Red Cross Blood Transfusion Service (permission no 29/2014, renewed annually). Animal 110 
immunizations related to this study were approved by the Ethical Committee of National Institute for 111 
Health and Welfare (permission KTL 2008-02). 112 
Cell cultures. Monocytes were purified from freshly collected, leukocyte-rich buffy coats obtained 113 
from healthy blood donors (Finnish Red Cross Blood Transfusion Service, Helsinki) as described 114 
previously (25). Human peripheral blood mononuclear cells were isolated by density gradient 115 
centrifugation over a Ficoll-Paque gradient (Amersham Biosciences). To obtain monocytes for 116 
macrophage differentiation, mononuclear cells were allowed to adhere to plates (Falcon, Becton 117 
Dickinson) for 1 h at +37°C in RPMI-1640 (Sigma-Aldrich) supplemented with 0.6 μg/ml penicillin, 118 
60 μg/ml streptomycin, 2 mM L-glutamine, and 20 mM HEPES. Non-adherent cells were removed by 119 
washing with cold PBS and remaining monocytes were cultured in macrophage/serum-free medium 120 
(Life Technologies) supplemented with antibiotics and human rGM-CSF, 10 ng/ml (Nordic Biosite). 121 
The cells were differentiated into macrophages for 7 days changing fresh culture media every 2 days. 122 
In each experiment, 3 to 4 different donors were grown and used separately for infection experiments. 123 
To obtain monocyte-derived dendritic cells (moDCs), Ficoll-Paque gradient centrifugation was 124 
followed by Percoll gradient (Amersham Biosciences) centrifugation. The top layer containing 125 
monocytes was collected, and the remaining T and B cells were depleted using anti-CD3 and anti-126 
CD19 magnetic beads (Dynal). Monocytes were allowed to adhere to plates for 1 h at +37°C in RPMI-127 
1640 supplemented as above. Adherent monocytes were washed with PBS and immature moDCs were 128 
generated by cultivating cells in RPMI-1640 medium supplemented with 10% FCS (Integro), 10 ng/ml 129 
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human rGM-CSF, 20 ng/ml human rIL-4 (R&D Systems) and antibiotics. The cells were cultivated for 130 
6 days and fresh media was added every 2 days. 131 
Primary wild type (wt) and Irf3-/-Irf7-/- mouse embryonic fibroblasts (MEFs) and Rela-/-Rel-/-Nfκb1-/- 132 
(NF-κB KO) MEF cell line were kindly provided by Dr. A. Hoffmann, Signaling Systems Lab, Los 133 
Angeles. Primary wild type (Rig-I+/+), Rig-I-/-, Mda5 -/- and Rig-I-/-Mda5 -/- MEFs were obtained from 134 
mouse embryos and they were immortalized by rigorous passaging protocol to obtain wt and KO cell 135 
lines. The MEF cell lines were cultured in DMEM -medium supplemented with 0.6 µg/ml penicillin, 136 
60 µg/ml streptomycin, 2 mM L-glutamine, 20 mM HEPES and 10% FCS. 137 
Viruses and infection experiments. Human influenza A virus A/Beijing/353/89 (H3N2) and influenza 138 
B virus B/Shangdong/7/97 and Sendai virus (strain Cantell) were grown from a 10-5 dilution of stock 139 
virus in allantoic cavities of 11-day-old embryonated chicken eggs at +34°C for 3 days. Influenza stock 140 
virus titers were determined by a plaque assay on MDCK cells and were as follows: 6x107 PFU/ml for 141 
A/Beijing and 18x107 PFU/ml for B/Shangdong. The multiplicity of infection (MOI) was based on the 142 
titers determined in MDCK cells. The Sendai virus stock titer (6x109 PFU/ml) was previously 143 
determined in moDCs by flow cytometry (26). 144 
MoDCs, macrophages and MEFs were infected with influenza viruses for different times, as indicated 145 
in the figures. To obtain a synchronized infection for immunofluorescence assays, the viruses were 146 
adhered to cells on ice for 1 h after which the medium was replaced with warm medium (37oC) to 147 
allow the viruses to enter the cell. For infectivity experiments in macrophages the cells were washed 148 
and media replaced 1h after infection. If inhibitors were used, they were added onto the cells 30 min 149 
before infection. Inhibitors were purchased from Sigma Aldrich and the pretitrated, functional 150 
concentrations used were 10 nM BafilomycinA1, 80 μM Dynasore (27, 28) and cycloheximide 10 151 
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μg/ml. In LPS stimulation 100 ng of E.coli serotype O111:B4 LPS (Sigma Aldrich) was used/well. 152 
Cells were harvested and samples for qRT-PCR, immunoblotting or immunofluorescence were 153 
prepared.  154 
Quantitative reverse transcriptase polymerase chain reaction, qRT-PCR. Cells from different 155 
blood donors were harvested and pooled after virus infection, and total cellular RNA was isolated using 156 
the RNEasy Mini kit (Qiagen) including DNase digestion (RNase-free DNase kit, Qiagen). One μg of 157 
total cellular RNA was reverse transcribed into cDNA in TaqMan RT buffer with 5.5 mM MgCl2, 500 158 
μM dNTPs, 2.5 μM Random hexamers, 0.4 U/μL RNase inhibitor and 1.25 U/μL MultiScribe reverse 159 
transcriptase (Applied Biosystems). cDNA samples were then amplified in TaqMan universal PCR 160 
master mix buffer (Applied Biosystems) with Gene Expression system assay mix oligonucleotides 161 
(Applied Biosystems) to analyze mRNA levels for human IFN-β1 (Hs00277188_s1), IFN-λ1 162 
(Hs00601677_g1), RIG-I (Hs00225561_m1), IFITM3 (Hs01922752_s1) and mouse IFN-β1 163 
(Mm00439552_s1), CXCL10 (Mm00445235_m1), TNF-α (Mm00443260_g1), and IAV or IBV NP 164 
and NS1 (24). Each cDNA sample was amplified in duplicate or triplicate with Mx3500P (Agilent 165 
Technologies). The mRNA levels were normalized against human 18S rRNA or mouse GAPD with 166 
TaqMan Endogenous Control kits (Applied Biosystems) and the amounts of cytokine mRNAs relative 167 
to unstimulated cells were calculated with the ΔΔCt –method as instructed by the manufacturer. 168 
Immunoblotting. For protein analyses the cells from different blood donors were collected, washed 169 
with PBS and pooled, and whole cell lysates were prepared in passive lysis buffer of Dual Luciferase 170 
Assay Kit (Promega) containing 1mM Na3VO4 and Complete protease inhibitor (Roche). MEF cells 171 
were lysed with RIPA buffer (1%Triton-X-100, 1% sodium deoxycholate, 0.1% SDS, 0.15 M NaCl, 172 
0.01 M sodium phosphate, pH 7.2) containing 1mM Na3VO4 and Complete protease inhibitor (Roche). 173 
Total cellular proteins were denatured in the Laemmli sample buffer and boiled. Equal amounts of 174 
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proteins were separated on SDS-PAGE and transferred to Hybond-P polyvinylidene difluoride (PVDF) 175 
membranes (Amersham Biosciences). The membranes were blocked for 1 h at RT with 5% milk in 176 
PBS (blocking buffer). The rabbit antibodies against human IRF3, influenza A NS1 were prepared as 177 
described previously (26, 29). The antibody against influenza A virus NP was prepared in rabbits by 178 
immunizing the animals four times at 4-week intervals with an Escherichia coli -expressed  179 
glutathione-Sepharose -purified (Amersham Biosciences) glutathione S-transferase (GST)-NP fusion 180 
protein (100 μg/immunization/animal). The antibody against influenza B virus NP and NS1 were 181 
prepared similarly except 35 μg of baculovirus-expressed, histidine-tagged antigen purified with 182 
preparative SDS-page and 20 μg of baculovirus-expressed preparative SDS-page purified antigen with 183 
Freund’s adjuvant were used, respectively. The staining was performed in blocking buffer at room 184 
temperature for 1 h. Antibodies for human Ser396 phosphorylated IRF3 (p-IRF3, #4947), IRF3 185 
(#4302),  IκBα (#9242), and GAPDH (#2118) were from Cell Signaling Technology, and all these 186 
antibodies recognize also mouse proteins. The staining was performed in PBS containing 5% BSA at 187 
4°C overnight. Antibody against IFITM3 (AP1153a) was from Abgent and against actin (sc-10731) 188 
from Santa Cruz Biotechnology. HRP-conjugated antibodies (Dako) were used in the secondary 189 
staining at RT for 1 h. Protein bands were visualized on HyperMax films using an ECL plus system 190 
(GE Healthcare). 191 
Immunofluorescence microscopy. Macrophages were differentiated on glass coverslips and infected 192 
with influenza viruses at an MOI of 30, incubated on ice for 1 h, after which the virus inoculum was 193 
removed and replaced with warm media to allow virus entry to the cells at 37°C 5% CO2. After 194 
indicated times the cells were fixed with 3% paraformaldehyde at room temperature for 20 min, 195 
washed with PBS,  permeabilized with 0.1% Triton X-100 for 5 min, washed and blocked with 0.5% 196 
BSA in PBS for 30 min. The cells were stained for 45 min in PBS containing 0.5% BSA at 37°C with 197 
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guinea pig anti-NP antibodies (1:400 dilution) prepared similarly as the corresponding rabbit antibodies 198 
described in immunoblotting method, and rabbit anti-IRF3 (1:50 dilution) or mouse anti-LAMP1 (sc-199 
20011, Santa Cruz Biotechnology) or mouse anti-EEA1 (610456, BD Biosciences). Secondary 200 
antibodies were FITC-labelled goat anti-guinea pig, Rhodamine Red-X-labelled goat anti-rabbit and 201 
Rhodamine-labelled goat anti-mouse diluted at 1:100 (Jackson ImmunoResearch Laboratories). In 202 
infectivity experiments NucBlue® Fixed Cell ReadyProbes® Reagent (Life Technologies) was added 203 
to Alexa Fluor 488 (Life Technologies) secondary antibody to stain the nucleus. The coverslips were 204 
washed with PBS containing 0.05% Tween 20, then with distilled water, and mounted in 25% Mowiol 205 
(Polysciences) in 25 mM Tris-HCl, pH 7.5, 50% glycerol, and 2.5% 1,4-diazabicyclo[2.2.2.]octane. 206 
The cells were visualized under a Leica TCS SPE confocal microscope with 63x NA 1.40 oil objective 207 
with 1 Airy unit pinhole maintaining the same image acquisition settings for all acquired images. The 208 
cells in the infectivity experiments were analyzed with Zeiss Stallion fluorescence microscope with 209 
Hamamatsu ORCA-Flash 4.0 LT sCMOS camera and 20x NA 0.4 objective using Slidebook 6-210 
software (Inteligent Imaging Innovations). 211 
 212 
RESULTS 213 
Influenza A and B viruses induce IFN gene expression with different kinetics in human 214 
macrophages. We have shown previously that influenza B virus induces IFN gene expression more 215 
rapidly than influenza A in human moDCs and A549 cells (24). To extend these studies further, we 216 
analyzed IFN responses in human monocyte-derived macrophages. These primary cells were infected 217 
with influenza A/Beijing/353/89 and B/Shangdong/7/97 viruses at a multiplicity of infection (MOI) of 218 
5, based on the titers determined with a plaque assay in MDCK cells. The expression levels of IFN-λ1, 219 
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IFN-β, viral NP and NS1, RIG-I and IFITM3 mRNA were analyzed by qRT-PCR at different time 220 
points. In these human macrophages, influenza B virus induced maximal IFN-λ1 and IFN-β mRNA 221 
expression within 2 to 4 hours whereas the maximum IFN mRNA levels after influenza A virus 222 
infection were seen at 16 to 24 hours (Fig. 1A). No substantial differences were observed in viral NP 223 
gene expression suggesting that both viruses replicated equivalently in macrophages. The kinetics of 224 
expression of IFN-inducible genes RIG-I and IFITM3 after influenza A and B virus infection mirrored 225 
the kinetics of IFN mRNA expression. The effect of virus dose on the kinetics of IFN-λ1 and NP gene 226 
expression was studied with MOIs of 1, 5, 25 and 125 in macrophages (Fig. 1B). Even though the 227 
increasing virus amount did accelerate the early IFN-λ1 gene expression, influenza B virus was clearly 228 
more efficient in inducing IFN-λ1 in the 2 hour time point. The MOI values are presented as titers 229 
determined in MDCK cells throughout the study to be able to better compare the virus amount used in 230 
different cell types. We also confirmed the infectivity in macrophages of four different donors with 231 
immunofluorescence assay (Fig. 1C). Based on qRT-PCR data influenza A and B viruses appeared to 232 
replicate equally well in the human macrophages (Fig. 1B, NP panel), while influenza B showed 233 
apparently 5-fold better infectivity compared to influenza A virus, as judged by immunofluorescence 234 
assay (Fig. 1C). 235 
Influenza-induced early IFN gene expression correlates with the activation of IRF3. IRF3 is a key 236 
transcription factor regulating early IFN gene expression, with NF-κB having a contributing role. To 237 
analyze whether there were differences in the kinetics and extent of activation of these transcription 238 
factors in influenza A and B virus-infected macrophages, we examined the phosphorylation status of 239 
IRF3 and the degradation of NF-κB inhibitor α (IκBα) by Western blotting (WB) at different time 240 
points of infection (Fig.2). In addition, the protein expression of IFN-inducible MxA and viral NP and 241 
NS1 was studied. Also the nuclear accumulation of IRF3 in macrophages was visualized by 242 
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immunofluorescence microscopy (Fig. 3). The phosphorylation of IRF3 correlated with the kinetics of 243 
IFN-λ1 and IFN-β gene expression (see Fig. 1A), as the phosphorylation of IRF3 was apparent at 1h 244 
and peaked at 2h time point in influenza B virus-infected macrophages (Fig. 2). In comparison, 245 
influenza A virus-induced IRF3 phosphorylation was visible at 4 hours and was further enhanced at the 246 
8 and 24 h time points. The degradation of IκBα, which precedes the activation of NF-κB, was weakly 247 
detectable at the 2h time point for influenza B and at the 8 and 24h time points in influenza A virus-248 
infected cells. 249 
In immunofluorescence microscopy experiments macrophages were infected with influenza A and B 250 
viruses at a high MOI of 30 and placed on ice for 1h to obtain a synchronized infection. The high MOI 251 
was used to be able to detect the incoming virus with the NP antibody and to confirm that all the cells 252 
were infected. The infection and internalization of viruses was triggered by increasing the temperature 253 
to 37°C and nuclear accumulation of viral NP and IRF3 into the nucleus was monitored over a 3h time 254 
course. At 1h after warming of cells, IRF3 was observed in the nucleus in influenza B virus-infected 255 
macrophages (Fig. 3A) whereas in influenza A virus-infected cells IRF3 nuclear translocation was not 256 
detected during the early phase (Fig. 3B). By 3 h after synchronized infection influenza A and B virus 257 
replication occurred, since viral NP accumulated into the nucleus. 258 
IRF3 and IRF7 transcription factors are indispensable for the influenza B virus-induced IFN-β 259 
and proinflammatory cytokine gene expression. To define the signaling pathway(s) responsible for 260 
influenza B virus-induced IFN/cytokine gene expression we took advantage of a cell line generated 261 
from mouse embryonic fibroblast (MEF) cells lacking functional IRF3 and IRF7 or NF-κB genes. Wild 262 
type (wt) and IRF3/7 double KO cells were infected with influenza A and B viruses with an MOI of 15 263 
for different times and cytokine gene expression was analyzed by qRT-PCR. A higher MOI of 15 264 
compared to the MOI of 5 in macrophages was used because the mouse cells appeared to be more 265 
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resistant to human influenza viruses. In wt mouse fibroblasts, influenza B virus induced a maximal 266 
IFN-β gene expression by 3 hours whereas in influenza A virus-infected cells IFN-β gene expression 267 
did not peak until 24 hours after infection (Fig. 4A). As expected, neither influenza B nor A virus 268 
induced IFN-β gene expression in IRF3/7 KO cells although both viruses infected wt and KO cells with 269 
almost equal kinetics and efficacy as analyzed by monitoring viral NP and NS1 expression by WB and 270 
qRT-PCR (Fig. 4A and 4B). We also analyzed the expression of CXCL10 and TNF-α mRNAs and 271 
found that in influenza B virus-infected IRF3/7 KO cells the expression of both of these genes was also 272 
absent. However, influenza A virus infection readily induced the expression of CXCL10 and TNF-α 273 
mRNA in both wt and IRF3/7 KO cells. We also analyzed the phosphorylation of IRF3 in mouse cells 274 
by WB; although we found weaker IRF3 phosphorylation in general, there was a clear kinetic 275 
difference between influenza A and B viruses (Fig. 4B), as seen in human macrophages. In wt MEFs 276 
IκBα degradation occurred at 1h time point in influenza A virus-infected cells whereas no clear 277 
degradation of IκBα was observed in influenza B virus-infected cells. We also analyzed IFN-β gene 278 
expression in triple KO MEFs lacking the NF-κB components p65, c-Rel and p105. Early IFN-β gene 279 
expression was reduced to some extent (10 to 40-fold) in influenza B virus-infected NF-κB KO cells 280 
(Fig. 4C). 281 
IRF3 is activated after influenza B virus vRNPs are released into the cytosol from the endosomal 282 
pathway. To correlate the stage in the viral lifecycle with IRF3 activation by influenza B virus we 283 
analyzed influenza B virus-infected macrophages at 15-minute intervals and stained for viral NP 284 
protein (green) to visualize virus entry and IRF3 (red) to define its nuclear accumulation (Fig 5). 285 
Viruses were allowed to attach the cells on ice for 1 h followed by a change of media (37oC) and chase 286 
for up to 3 h. In confocal images at time point 0’ the NP was localized at the plasma membrane. Within 287 
15 min of incubation at 37oC we detected green granules inside the cells and between 30 and 45 min 288 
14 
 
some NP localized in the nucleus. At one hour viral NP accumulated in the nucleus and at 3 hours 289 
newly synthesized NP was seen. We confirmed that the NP at the 3 h time point was nascently 290 
generated since enhanced accumulation of NP in the nucleus was not seen in cycloheximide (CHX) 291 
treated cells (Fig. 5, compare IBV DMSO vs. CHX). The activation and nuclear import of IRF3 292 
occurred within 45 to 60 min and correlated with the entry of viral vRNPs into the nucleus. This 293 
suggested that IRF3 is activated after influenza B vRNPs are released into the cytoplasm. To confirm 294 
this hypothesis we used a specific inhibitor of vacuolar H+ ATPase, Bafilomycin A1 (BafA1), which 295 
prevents the acidification of the endosomes required for influenza virus entry into the cytosol. In the 296 
presence of BafA1, nuclear accumulation of viral NP or IRF3 was not detected (Fig. 5, lower panels).  297 
To link these findings to the innate immune signaling phenotypes, we analyzed IFN-λ1 gene expression 298 
in BafA1-treated macrophages (Fig. 6A) and moDCs (Fig. 6B). BafA1 treatment reduced the early 299 
phase of influenza B virus-induced IFN-λ1 gene expression. The phosphorylation of IRF3 also was 300 
reduced in BafA1-treated cells at the 2h and 3h time points in moDCs (Fig. 6B left panel), consistent 301 
with the observed inhibition of nuclear translocation of IRF3 in macrophages (Fig. 5). A dynamin-302 
inhibitor, Dynasore, which prevents clathrin-mediated endocytosis, also blocked the early phase of 303 
influenza B virus-induced IFN-λ1 gene expression and IRF3 phosphorylation in moDCs (Fig. 6B, left 304 
panel). As a control we treated cells with LPS, which is recognized by TLR4 and does not need 305 
endosomal acidification for signaling. As expected, BafA1 did not inhibit LPS induced IFN-λ1 gene 306 
expression in moDCs (Fig. 6B right panel). However, TLR4 receptor is sensitive to Dynasore since it 307 
needs to be endocytosed before signaling via TRIF adaptor leading to IFN gene expression (30). As 308 
another control we used Sendai virus, which fuses directly at the plasma membrane. As expected, 309 




Although the kinetics of the different phases of influenza A virus entry have been described previously 312 
(31, 32), such an information for influenza B virus is limited. In our experiments the entry of influenza 313 
B virus seemed to be rapid, as in less than 1 hour the viral NP entered the nucleus. To define this 314 
further, we performed immunofluorescence microscopy experiments to determine whether influenza B 315 
virus also uses early and late endosomes for its entry. We co-stained with EEA1 for early endosome or 316 
LAMP1 for late endosome/lysosome, and influenza B virus NP. Colocalization of EEA1 with influenza 317 
B virus NP was detected within 15 to 30 min and some colocalization with LAMP1 and NP was seen at 318 
30 min (Fig. 7, see insets in lower panels). In BafA1-treated macrophages influenza B virus NP did not 319 
enter the nucleus and the colocalization with the endosomal markers was sustained for 1 to 2 hours 320 
with EEA1 and even to 4 hours with LAMP1. We also analyzed IRF3 activation in the same 321 
experiment and found it occurred at 1 h time point, after colocalization of viral NP with the endosomal 322 
markers (Fig. 7, upper 2 panels). 323 
 324 
RIG-I is essential for the influenza B virus-induced early IRF3 activation. To elucidate which of 325 
the RLR receptors was responsible for the early innate immune recognition of influenza B virus 326 
infection we used MEFs lacking RIG-I, MDA5 or both proteins (7, 33). We infected wt and single and 327 
double receptor KO MEFs with influenza B and influenza A viruses at an MOI of 30 and analyzed the 328 
expression of IFN-β and viral NS1 RNA by qRT-PCR (Fig. 8A) and the phosphorylation of IRF3 and 329 
expression of NP and NS1 by WB (Fig. 8B). As the phosphorylation of IRF3 was weak in mouse cells 330 
(Fig. 4B) a high amount of virus was used to better visualize the activation of IRF3. In RIG-I-/- cells, 331 
influenza B virus induced IFN-β gene expression was completely absent; whereas in influenza A virus-332 
infected cells primarily the early IFN gene expression (2 and 4 h) was missing or reduced (Fig. 8A). 333 
The early activation of IRF3 was RIG-I-dependent since influenza B virus-induced IRF3 334 
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phosphorylation did not take place in RIG-I-/- MEFs (Fig. 8B). In contrast, in MDA5 KO cells, IRF3 335 
phosphorylation was induced normally by influenza B virus infection. The experiment also revealed 336 
differences between influenza A and B viruses. Unlike influenza B virus, influenza A virus showed 337 
some residual IFN gene expression activity also in RIG-I KO cells and IRF3 phosphorylation was 338 
reduced both in RIG-I or MDA5 single KO cells. 339 
 340 
DISCUSSION 341 
In the present study we analyzed the mechanisms of activation of innate immune responses in human 342 
monocyte-derived macrophages and dendritic cells after influenza A and B virus infections. We show 343 
that in human macrophages influenza B virus activates IRF3 phosphorylation and induces its nuclear 344 
accumulation soon after infection. This is followed by activation of IFN-λ1 and IFN-β gene expression 345 
and induction of IFN-stimulated genes (ISG), including RIG-I and IFITM3. In influenza A virus 346 
infected cells, these genes were induced with slower kinetics. IRF3 activation after influenza B virus 347 
infection occurred in the presence of protein synthesis inhibitor, CHX indicating that its activation and 348 
IFN gene expression is triggered directly by the incoming virus. Blocking influenza B virus vRNP 349 
release from endosomes with pharmacological inhibitors prevented the early activation of innate 350 
immune response. Finally, by using KO MEFs, we demonstrate that IRF3 and RIG-I play a crucial role 351 
in influenza B virus induced early IFN gene expression. 352 
The present study was carried out mainly in human macrophages, in contrast to previously used 353 
moDCs (24). Tissue resident alveolar macrophages are the first line innate immune cells to fight 354 
influenza infection and also are possible targets of infection in the lungs (34). Analogous to studies in 355 
moDCs and A549 cells (24), influenza B virus induced IRF3 phosphorylation and IFN and ISG gene 356 
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expression in macrophages at early times after infection. Influenza B virus does not readily infect 357 
mouse cells and this species specificity depends partially on the viral NS1 protein which binds and 358 
inhibits the antiviral action of human but not mouse ISG15 (35). In MEFs, influenza B virus has 359 
previously been shown to induce IFIT2 and ISG15 in a RIG-I dependent manner (7) and in agreement 360 
with this data, we also detected RIG-I and IRF3/7 dependent IFN-β gene expression and IRF3 361 
activation in MEFs. 362 
Previously we showed that UV-treated, inactivated influenza B virus still induced IFN gene expression 363 
in human moDCs whereas UV-treated influenza A virus did not (24). UV irradiation of the virus is 364 
thought to block the primary transcription possibly due to the uracil dimers generated by the radiation. 365 
A recent study analyzed influenza A virus-induced IRF3 activation in the presence of chemical 366 
inhibitors, including actinomycin D, which blocks the primary transcription of the virus (12). This 367 
paper showed that the primary transcription but not the replication of influenza A was needed to 368 
activate IRF3. Another recent study carried out with several negative sense RNA viruses suggested that 369 
the incoming viral nucleocapsid containing a 5’-triphosphate genome can activate RIG-I signaling 370 
without transcription of viral genes (13). A more recent study showed that RIG-I is activated by the 371 
incoming influenza A virus 5´ triphosphate dsRNA panhandle (14). Our data supports this latter model 372 
well, at least for influenza B virus infection, which triggers IRF3 activation at the earliest phase of 373 
infection when NP starts to accumulate into the nucleus and before any viral protein synthesis or 374 
replication takes place. However, we did not observe IRF3 activation after the entry of influenza A 375 
virus which is consistent with our previous data that UV-treated influenza A virus is incapable of 376 
inducing IFN gene expression (24). In the study by Killip and coworkers, innate immune responses and 377 
IRF3 activation were analyzed at a relatively late time point (8 h) (12). This time point may reflect 378 
detection of newly synthesized viral RNAs or replication intermediates. However, we clearly show that 379 
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influenza B virus activates IRF3 at 1 h post infection in a RIG-I-dependent manner, which means that 380 
RIG-I must sense the incoming vRNA structures. We hypothesize that even if the incoming influenza 381 
A nucleocapsids were recognized by RIG-I, the virus could have some RIG-I and/or MAVS signaling 382 
inhibitors that prevent IRF3 activation. Supporting this theory, Liedmann and coworkers described 383 
motifs in the polymerase proteins PB1 and PA of influenza A that seemed to inhibit IRF3 activation. 384 
When these sites were mutated, the mutant but not the wild type virus activated IRF3 at an 8 h time 385 
point (16). To further complicate things, Weber and coworkers showed that RIG-I itself could function 386 
as an antiviral protein by binding and inhibiting the incoming influenza A nucleocapsids, independently 387 
of IFN induction, and the mammalian adapted influenza A viruses with PB2-627K are more resistant to 388 
the direct antiviral action of RIG-I than avian influenza A viruses with PB2-627E sequences. It remains 389 
to be investigated whether influenza B virus has evolved similar RIG-I counteracting strategies. 390 
Regardless, our results indicate that in the human macrophages and moDCs IFN signaling is activated 391 
by the incoming influenza B virus. Perhaps influenza B virus polymerase complex is not as tightly 392 
associated with the viral genome in the vRNP complex compared with human adapted influenza A 393 
viruses and thus the influenza B virus panhandle structures are more accessible for RIG-I recognition.  394 
Banerjee and coworkers have recently developed an image-based assay to study the precise kinetics of 395 
influenza virus entry (31). The steps from endocytosis to HA acidification and from acidification to 396 
membrane fusion were rapid, but after membrane fusion a 45 min lag period was estimated to occur 397 
between membrane fusion and vRNP uncoating. We observed influenza B NP in the nucleus already at 398 
1 h post infection and speculate that in the case of influenza B virus, viral and endosomal membrane 399 
fusion and uncoating may occur more rapidly than for influenza A virus resulting in faster entry into 400 
the nucleus. For this phenomenon there may be a couple of explanations: (a) influenza B virus HA 401 
fusion peptide is more exposed, which may lead to membrane fusion at higher pH and accelerated 402 
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fusion kinetics compared to influenza A virus (32); (b) the uncoating of influenza A virus takes place 403 
when the virion gets acidified via viral M2 ion channel leading to dissociation of M1 protein. As 404 
influenza B virus has an additional ion channel NB, the virion may become acidified more efficiently 405 
and thus the vRNPs may be released into the cytoplasm earlier. However, NB ion channel is likely not 406 
the only contributing factor as mutating this ion channel leads to reduced IRF3 activation compared to 407 
wt virus but still the activation of IRF3 is more efficient than with influenza A virus (data not shown). 408 
As viral vRNPs are released earlier from the endosome and uncoated, they may be recognized sooner 409 
as foreign RNA structures via cytosolic PRRs. 410 
Innate immunity receptors known to recognize viral RNA structures are RIG-I, MDA5, TLR3, TLR7 411 
and TLR8. Macrophages and dendritic cells are equipped with a range of innate immune receptors to 412 
recognize foreign microbial structures. As influenza viruses enter the cells via an endosomal pathway, 413 
where TLR3, 7 and 8 are localized, viral entry could be recognized in the endosomes. This occurs in 414 
plasmacytoid DCs (pDCs), which express low levels of RLRs (36) but high levels of endosomal TLR7 415 
and IRF7 and produce high amounts of IFN-α during influenza A virus infection (11). It is possible that 416 
in pDCs some viruses cannot escape the endosomal pathway before degradation and thus viral RNA 417 
structures are released from the virion to be recognized by endosomal TLRs. Our experiments with 418 
BafA1 that result in the retention of influenza viruses in the endosomal pathway suggest that the 419 
incoming influenza B virus RNA is not recognized by TLRs in macrophages or moDCs. However, 420 
BafA1 treatment may affect the maturation and signaling of TLR receptors (37), so we cannot fully 421 
exclude their role. Nevertheless, experiments in knock-out MEFs suggested that the early influenza B 422 
virus-induced innate immune responses are mediated by RIG-I in the cytosol. In summary, we have 423 
demonstrated significant differences between influenza A and B virus infection in their ability to 424 
activate early innate immune responses in primary human immune cells. A better understanding of the 425 
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early entry and immune recognition events may help to explain the pathogenesis of influenza A and B 426 
virus infections and provide us the means to develop efficient intracellular viral inhibitors. 427 
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FIGURE LEGENDS 558 
Figure 1. Kinetics of influenza-induced IFN gene expression in human macrophages. (A) Human 559 
monocyte-derived macrophages were infected with influenza virus strains A/Beijing/353/89 (IAV) and 560 
B/Shangdong/7/97 (IBV) at an MOI of 5 for different times as indicated in the figure. Cells from 3 561 
donors were pooled, total cellular RNA was isolated, and IFN, viral NP and NS1, RIG-I and IFITM3 562 
gene expression was measured by qRT-PCR and fold induction over the mock-infected sample or 1 h 563 
infected sample (NP and NS1) was calculated. (B) Macrophages from four donors were infected as 564 
above with an MOI of 1, 5, 25 or 125 for different times and IFN-λ1 and viral NP gene expression was 565 
analyzed with qRT-PCR. The results are presented as the means (+ 1 standard deviation of the means) 566 
of two to three technical replicates and are from a representative experiment out of three (A) or two 567 
(B). (C) Macrophages were grown on coverslips and infected with viruses as above with MOIs from 25 568 
to 0.04 for 16 h. The coverslips were prepared for immunofluorescence and stained with guinea pig 569 
anti-influenza A or B NP and nuclear stain using Alexa Fluor 488 conjugated anti-guinea pig secondary 570 
antibody. The mean percentage of NP positive cells from four donors is presented with one SD unit and 571 
altogether 8 donors were analyzed.   572 
Figure 2. IRF3 activation correlates with an early influenza B virus-induced IFN response. 573 
Macrophages were infected with influenza A/Beijing/353/89 and B/Shangdong/7/97 viruses (MOI of 5) 574 
and cells from 3 donors were collected at different time points and pooled. Whole-cell lysates were 575 
prepared for SDS-PAGE and immunoblot analysis with antibodies against p-IRF3, IκBα, IRF3, 576 
influenza A and B virus NP and NS1 and MxA was carried out. Actin and GAPDH protein levels were 577 




Figure 3. IRF3 and influenza B virus NP accumulate in the nucleus simultaneously in 580 
macrophages. Human macrophages were differentiated on coverslips followed by infection with (A) 581 
influenza B/Shangdong/7/97 and (B) influenza A/Beijing/353/89 viruses with an MOI of 30 on ice for 582 
1 h. Subsequently, virus entry proceeded after warming to 37°C and cells were fixed with PFA after 583 
indicated incubation times. Guinea-pig anti-NP antibodies were used to detect influenza A or B virus 584 
NP (green) and rabbit anti-human IRF3 was used to stain for IRF3 (red), secondary antibodies were 585 
FITC-labelled donkey anti-guinea-pig and Rhodamine Red-X-labeled donkey anti-rabbit 586 
immunoglobulins. Second row of images shows insets of NP stainings indicated by white rectangular.  587 
Data shown is representative of four independent experiments on cells from 11 donors. 588 
Figure 4. IRF3 and IRF7 transcription factors are essential for influenza virus induced IFN gene 589 
expression. (A and B) Wt MEFs and MEFs lacking IRF3 and IRF7 transcription factors (IRF3/7) were 590 
infected with influenza A/Beijing/353/89 and B/Shangdong/7/97 viruses with an MOI of 15 for 591 
indicated times. RNA samples were collected for analyzing the gene expression of IFN-β, viral NP and 592 
NS1, TNF-α and CXCL10 genes by qRT-PCR (A) and protein samples were prepared for immunoblot 593 
analysis with antibodies against p-IRF3, IRF3, IκBα and influenza A and B virus NP and NS1 (B). 594 
GAPDH protein levels were analyzed to control equal loading. (C)  Wt MEFs and MEFs lacking the 595 
NF-κB components p65, c-Rel, and p105 (NF-κB) were infected with influenza A/Beijing/353/89 and 596 
B/Shangdong/7/97 viruses with an MOI of 15 for indicated times. RNA samples were collected for 597 
analyzing the gene expression of IFN-β and viral NP genes by qRT-PCR. The qRT-PCR data is 598 
presented as relative gene expression levels for viral NP gene in relation to that of the 30 min or 1h 599 
sample and for cytokine genes in relation to those of the mock-infected samples. The results are 600 
presented as the means from triplicate measurements with 1 SD units and representative experiments 601 
out of two are shown. 602 
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Figure 5. Endosomal acidification but not de novo protein synthesis is needed for influenza B 603 
virus induced IRF3 activation. Human macrophages were differentiated on coverslips followed by 604 
infection with influenza B/Shangdong/7/97 virus with an MOI of 30 on ice for 1 h. Subsequently, virus 605 
entry proceeded after warming to 37°C and cells were fixed with PFA after indicated incubation times. 606 
The inhibitors, BafA1 and CHX or DMSO vehicle were added to the cells 30 min before infection. 607 
Guinea-pig anti-NP antibodies were used to detect influenza B virus NP (green) and rabbit anti-human 608 
IRF3 was used to stain IRF3 (red), secondary antibodies were FITC-labelled donkey anti-guinea-pig 609 
and Rhodamine Red-X-labelled donkey anti-rabbit immunoglobulins. Under each frame an inset of one 610 
cell marked with a white rectangular is presented. Data shown is representative of two independent 611 
experiments on cells from 6 donors. 612 
Figure 6. Inhibition of endosomal acidification decreases early influenza B virus-induced IFN 613 
gene expression in human monocyte-derived macrophages and dendritic cells. (A) Macrophages 614 
were treated with BafA1 or vehicle control followed by infection with influenza A/Beijing/353/89, 615 
B/Shangdong/7/97 or Sendai viruses with an MOI of 5 with times indicated in the figure. The cells 616 
from 4 donors were pooled for isolation of total cellular RNA and qRT-PCR analysis of IFN-λ1 gene 617 
expression. The data is presented as fold induction over mock-infected sample as the means of three 618 
technical replicates with 1 SD unit. (B) MoDCs were treated with BafA1, Dynasore or vehicle control 619 
followed by infection with influenza B/Shangdong/7/97 (MOI of 5) (left panel) or stimulated with LPS 620 
(right panel) for different times. The cells from 4 donors were pooled for qRT-PCR analysis of IFN-λ1 621 
gene expression and WB analysis for p-IRF3, IκBα, IRF3, and influenza B virus NP expression. 622 
GAPDH protein levels were analyzed to control for equal protein loading. The data is representative of 623 
two to three independent experiments. 624 
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Figure 7. Influenza B NP colocalizes with classical markers of the endosomal pathway. Human 625 
macrophages were differentiated on glass coverslips and infected with influenza B/Shangdong/7/97 626 
virus with an MOI of 30 on ice for 1 h. Virus entry proceeded after warming to 37°C and cells were 627 
fixed with PFA after indicated incubation times. BafA1 or DMSO was added to the cells 30 min before 628 
infection. Primary antibodies used were guinea-pig anti-NP IBV, rabbit anti-human IRF3, mouse anti-629 
EEA1 and mouse anti-LAMP1. Secondary antibodies were FITC-labelled donkey anti-guinea-pig and 630 
Rhodamine Red-X-labelled donkey anti-rabbit and rhodamine-labelled goat anti-mouse 631 
immunoglobulins. Insets of 15, 30 and 60 minute time points are visualized in the lower panel and 632 
marked with white rectangulars in the upper panels. One representative experiment out of two is 633 
shown. 634 
Figure 8. RIG-I receptor is responsible for the early influenza B virus-induced IRF3 635 
phosphorylation and activation. (A) Wt (RIG-I+/+) MEFs and MEFs lacking RIG-I, MDA5 or both 636 
receptors were infected with influenza A/Beijing/353/89 and B/Shangdong/7/97 viruses with an MOI 637 
of 30 for indicated times. Cells were collected and total cellular RNA was isolated for qRT-PCR 638 
analysis of IFN-β and viral NS1 gene expression. The qRT-PCR data is presented as fold induction 639 
over mock-infected samples and the means with 1 SD units from triplicate measurements are shown.  640 
(B) Protein samples were isolated for the analysis of p-IRF3, viral NP and NS1 and GAPDH by WB. A 641 
representative experiment out of three is shown. 642 








